A Study Of Patient Use Of Conversational AI For Chronic Hematologic Conditions

Overview

About this study

The purpose of this study is to describe patient-reported use of conversational AI or chatbot tools for health-related purposes among respondents with CLL or MGUS, overall and by condition group.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adult (aged 18+)

  • Documented diagnosis of CLL (ICD-10 code: C91.1*) or MGUS (D47.2)

  • Provided research authorization

 

Exclusion Criteria: 

  • Listed on Mayo Clinic do not contact list

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 08/10/2026. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Lindsey Philpot, Ph.D., M.P.H.

Open for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions